{"brief_title": "MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044)", "brief_summary": "This study is a double-blind, randomized study of MK0991 versus liposomal amphotericin B in the empirical treatment of pediatric patients (ages 2 through 17 years) who have an absolute neutrophil count (ANC) below 500/microliter and who have fever despite broad antibiotic coverage. Such patients would be candidates for empirical therapy with an intravenous anti-fungal agent.", "condition": "Fever", "intervention_type": "Drug", "intervention_name": "Comparator: AmBisome", "description": "Duration of Treatment: 28-90 days", "other_name": "MK0991", "criteria": "Inclusion Criteria: - Patients who are 2 through 17 years of age - Absolute Neutrophil Count (ANC) is below 500/microliter - Have persistent fever (at least 4 days) despite antibiotic therapy", "gender": "All", "minimum_age": "2 Years", "maximum_age": "17 Years", "healthy_volunteers": "No", "id": "NCT00082537.xml"}